Description
- Proven effective in reducing or eliminating urinary incontinence¹
- 93% of dogs treated were improved or continent by 6 weeks¹
- Convenient, once-a-day dosing
- One simple starting dose for all female dogs
- 1. Byron JK, Taylor KH, Phillips GS, and Stahl MS. Urethral Sphincter Mechanism Incompetence in 163 Neutered Female Dogs: Diagnosis, Treatment, and Relationship of Weight and Age at Neuter to Development of Disease. J Vet Intern Med. 2017;31:442–448.
| Item Weight | 0.1 ounces |
|---|---|
| Manufacturer | Merck |
| Item model number | 22108456PK |
| Target Audience Keyword | dogs |
| Directions | Tablets administered orally. All dogs start out with a once-daily dose of two 1 mg Incurin tablets regardless of body weight. Titrated to the lowest effective dose. |
| Model Name | INCURIN Tablets for Dogs |
| Size | 1mg |
| Included Components | Package |
| Specific Uses for Product | Urinary |
INCURIN (estriol) Tablets are an effective treatment for the control of estrogen-responsive urinary incontinence in spayed female dogs that contains estriol, a naturally occurring, short-acting estrogen found in female dogs, with the convenience of once-a-day dosing.
Important Safety Information
INCURIN (estriol) Tablets: INCURIN is indicated for the control of estrogen-responsive urinary incontinence in ovariohysterectomized dogs. The most common side effects associated with INCURIN treatment under field conditions included loss of appetite, vomiting, excessive water drinking, and swollen vulva. The safety and effectiveness of INCURIN Tablets have not been evaluated in dogs less than 1 year of age, intact female dogs, male dogs, dogs used for breeding, or lactating dogs. INCURIN is contraindicated in dogs showing polyuria secondary to polydipsia, or in pregnant dogs. Please see the product label for full prescribing information. For additional information, please see the product label.
Reviews
There are no reviews yet.